Our current understanding involves the glioma-expressed branched-chain amino acid transaminase 1 (BCAT1) that transfers α-amino groups from branched-chain amino acids to α-ketoglutarate, thereby producing glutamate and the respective branched-chain α-ketoacid (Tönjes et al., 2013). Here, BCAT1 is linked to central nervous system cancer.